2-碘己酸 | 7425-31-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 2-碘己酸
• 英文名称: 2-iodohexanoic acid
• 英文别名: 2-iodocaproic acid
• CAS: 7425-31-2
• 化学式: C₆H₁₁IO₂
• 分子量: 242.057
• InChiKey: BWVAFGCIEDGPRY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  9
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-碘己酸 以25%的产率得到己酸
  参考文献：
  名称：

  High-temperature transnitrilation of 2-bromocaproic acid

  摘要：

  Chromato-mass spectrometry and IR and PMR spectroscopy were used to study the high-temperature reaction of 2-bromocaproic, 2-iodocaproic, and 2-bromo-2-phenyl-acetic acids with acetonitrile. The formation of anomalous transnitrilation products (capronitrile and benzyl cyanide) is a consequence of the initial conversion of 2-halo-substituted caproic and phenylacetic acids to caproic and phenylacetic acids, respectively.

  DOI：

  10.1007/bf00957883
• 作为产物：
  描述：

  2-溴己酸 在 sodium iodide 作用下， 以 丁酮 为溶剂， 反应 7.0h， 以20%的产率得到2-碘己酸
  参考文献：
  名称：

  新型N-α-卤代高丝氨酸内酯作为群体感应调节剂的合成和生物学评估。

  摘要：

  已经研究了新型N-α-卤代高丝氨酸内酯，其中在N-酰基链的羰基官能团的α-位置引入了卤素原子，作为群体感应（QS）调节剂，并与天然N库进行了比较酰化的高丝氨酸内酯（AHL）。该系列新的类似物由α-氯，α-溴和α-碘的AHL类似物组成。此外，评估了与天然AHL相比，合成AHL类似物的生物学QS活性。卤代类似物在大肠杆菌JB523生物测定中显示出降低的活性，其中α-碘内酯的活性较低，而α-氯代AHL的效力最强。当在QS抑制测试中进行测试时，大多数α-卤代酰化类似物没有表现出明显的减少。所以，

  DOI：

  10.3762/bjoc.10.265

文献信息

• Water soluble fluorescent compounds
  申请人：Reddington Mark

  公开号：US20070021621A1

  公开（公告）日：2007-01-25

  The invention provides a novel class of fluorescent compounds. Also provided are conjugates of the fluorescent compounds, methods of using the fluorescent compounds and their conjugates as well as kits including the fluorescent compounds and their conjugates.

  这项发明提供了一类新型荧光化合物。还提供了荧光化合物的共轭物，使用荧光化合物及其共轭物的方法，以及包括荧光化合物及其共轭物的试剂盒。
• Oxidative coupling of carboxylic acid dianions
  作者：J.L. Belletire、E.G. Spletzer、A.R. Pinhas

  DOI：10.1016/s0040-4039(01)81735-4

  日期：1984.1

  The conditions, scope, and stereochemical consequences of a versatile approach to succinic acid derivatives are described.

  描述了一种通用方法制备琥珀酸衍生物的条件，范围和立体化学结果。
• [EN] COMPOUND HAVING BISAZO SKELETON, PIGMENT DISPERSANT CONTAINING THE COMPOUND, PIGMENT COMPOSITION, PIGMENT DISPERSION, INK AND RESIST COMPOSITION FOR COLOR FILTER<br/>[FR] COMPOSÉ AYANT UN SQUELETTE BISAZO, DISPERSANT DE PIGMENT CONTENANT LE COMPOSÉ, COMPOSITION DE PIGMENT, DISPERSION DE PIGMENT, ENCRE ET COMPOSITION DE RÉSERVE POUR UN FILTRE COLORÉ
  申请人：CANON KK

  公开号：WO2013054938A1

  公开（公告）日：2013-04-18

  An object of the present invention is to provide a pigment dispersant in which dispersibility of an azo pigment in a water-insoluble solvent is improved, and to provide an azo pigment composition in which the azo pigment has high dispersibility in a water-insoluble solvent. The present invention provides a compound used as a pigment dispersant and having a structure in which a specific bisazo skeleton unit bonds to a specific polymer resin unit.

  本发明的一个目的是提供一种颜料分散剂，其中改善了偶氮颜料在水不溶性溶剂中的分散性，并提供了一种偶氮颜料组合物，其中偶氮颜料在水不溶性溶剂中具有高分散性。本发明提供了一种化合物，用作颜料分散剂，其具有特定的双偶氮骨架单元与特定聚合物树脂单元结合的结构。
• COMPOUND HAVING AZO SKELETON, PIGMENT DISPERSANT, PIGMENT COMPOSITION, PIGMENT DISPERSION, AND TONER
  申请人：CANON KABUSHIKI KAISHA

  公开号：US20160208106A1

  公开（公告）日：2016-07-21

  A compound that improves the dispersibility of pigments in non-water-soluble solvents is provided. A pigment dispersant, a pigment composition, a pigment dispersion, and a toner in which this compound is used are also provided. This compound has a polymer and a monoazo compound having a certain structure binding to each other. The pigment dispersant, the pigment composition, the pigment dispersion, and the toner contain this compound.

  提供了一种可以改善颜料在非水溶性溶剂中分散性的化合物。还提供了一种颜料分散剂、颜料组合物、颜料分散液和使用了这种化合物的色调剂。该化合物包含聚合物和一种具有特定结构的单偶氮化合物相互结合。颜料分散剂、颜料组合物、颜料分散液和色调剂均含有这种化合物。
• Chloroquine combination drugs and methods for their synthesis
  申请人：Kosak M. Kenneth

  公开号：US20070060499A1

  公开（公告）日：2007-03-15

  This invention discloses compositions of chloroquine-coupled active agents, including methods for their preparation. The prior art has shown that chloroquines given as free drug in high enough concentration, enhances the release of various agents from cellular endosomes into the cytoplasm. The purpose of these compositions is to provide a controlled amount of chloroquine at the same site where the active agent is delivered, thereby reducing the overall dosage needed. The compositions comprise a chloroquine substance coupled to an active agent directly or through a variety of pharmaceutical carrier substances. The carrier substances include polysaccharides, synthetic polymers, proteins, micelles and other substances for carrying and releasing the chloroquine compositions in the body for therapeutic effect. The compositions can also include a biocleavable linkage for carrying and releasing active agents for therapeutic or other medical uses. The invention also discloses carrier compositions that are coupled to targeting molecules for targeting the delivery of chloroquine substances and active agents to their site of action.

  这项发明揭示了氯喹偶联活性药剂的组合物，包括其制备方法。先前的技术已经表明，以足够高浓度给予氯喹作为游离药物，可以增强细胞内体内各种药剂从细胞内体释放到细胞质中。这些组合物的目的是在传递活性药剂的相同部位提供受控量的氯喹，从而减少所需的总剂量。这些组合物包括将氯喹物质直接或通过各种药用载体物质偶联到活性药剂。载体物质包括多糖、合成聚合物、蛋白质、胶束和其他用于在体内携带和释放氯喹组合物以产生治疗效果的物质。这些组合物还可以包括用于携带和释放活性药剂以用于治疗或其他医疗用途的生物可降解连接。该发明还揭示了与靶向分子偶联的载体组合物，用于将氯喹物质和活性药剂定位传递到它们的作用部位。